For babies in the NICU, their story has just begun. Find #answers that help get them out of the #NICU and onto the next chapter of their story. Learn how GeneDx can help.

Families want answers. #rWGS can help you get to the root cause of a #NICU patient’s condition - and can direct more personalized treatment. Learn how you can implement comprehensive genetic testing by visiting the GeneDx booth at the Nemours Children's Neonatology Conference.

Are you a healthcare provider working in a #NICU? Do you want to implement rapid genetic testing, but lack genetic specialist support? Learn how to interpret #genetic results & discuss them with caregivers, with insights from a panel of experts. bit.ly/3KV9ZEj

Incorporating #genomic #sequencing into your workflow doesn’t have to be complicated. Instead, let us do the heavy lifting. We can assist with: ✅ selecting appropriate tests ✅ answering clinical questions ✅ reporting patient-centric results ✅ guiding potential next steps

Five. That’s how many uninformative tests the average child with neurodevelopmental disorders undergoes in search of a #genetic diagnosis. Find critical information sooner by ordering #exome first. Test once, discover more, and help your #patients get the care they need earlier.

There’s no place like home for the #holidays. But for the most vulnerable patients, this isn’t always possible. Give them the gift of #genetic insights that can help inform diagnosis, direct treatment, & make sure they’re back where they belong: in the arms of their loved ones.

New year. New insights. New direction. The understanding gained through #genetic testing can hold so much promise for #patients and their families. That’s why for 2024, we’re committed to finding more answers for more patients.

📣 Preliminary 2023 financial results released! For more details, read our press release here: bit.ly/3RNTbBK

9 state Medicaid programs now cover rapid whole #genome #sequencing (rWGS) in the pediatric inpatient setting. Utah joins a growing list of states who recognize the importance of offering rWGS in the NICU & PICU to provide a rapid diagnosis for the most vulnerable patients.

GeneDx's 2023 financial results are now available. Join us today for our earnings call, where we'll discuss our financial and operating performance. For more details, read our press release here: genedx.co/3wkToVP

More patients need #genetic testing than there are genetics experts. How do we ensure they get the care they need? Join us for a collaborative brainstorming session at the 2024 #ACMG meeting, as we discuss patient access outside of the genetics clinic. ➡️ genedx.co/3wERK1B

📣Join us at the American College of Medical Genetics (#ACMG) Annual Meeting as we present new data demonstrating the clinical superiority of #ExomeSequencing. Exome finds answers that other tests can miss. Read more in our full press release: genedx.co/3TAFeJm

We’re taking the stage with Egetis Therapeutics and Effie Parks at World Orphan Drug Congress USA! Join us for a panel discussion on April 25 at 1:00pm to learn how we can bring new therapies to patients, faster, by working together. We’re looking forward to connecting in Boston!

Our latest Vanguards of Health Care episode dropped last week featuring GeneDx's CEO Katherine Stueland. She shared how they're trying to make multi-gene panels a thing of the past with exome testing and her views on testing's future. Listen here: open.spotify.com/episode/4AvjTW…

GeneDx's Q1 2024 financial results are now available. Join us today for our earnings call, where we'll discuss our financial and operating performance. For more details, read our press release. genedx.co/3wkWCZG

This is the last month to earn your CME credit! Learn about the expanding and vital role of rapid #Genomic sequencing in the NICU in the webcast: A #NICU Clinician's Guide to Rapid Whole #Genome Sequencing—before the webinar expires on May 24. bit.ly/3KV9ZEj

Exome sequencing is more likely to find a #genetic #diagnosis for epilepsy patients. It’s recommended as a first-line test for individuals with unexplained #epilepsy by the National Society of Genetic Counselors and endorsed by the American Epilepsy Society.

📣 GeneDx's Q2 2024 financial results are now available. Join us today for our earnings call, where we'll discuss our financial and operating performance. For more details, read our press release: genedx.co/3SxxZ46

Coming soon: Faster turnaround for rapid genome sequencing, buccal sample types accepted for patients receiving genome, and more. The result? Accelerated diagnoses for patients. For more details, read our press release: genedx.co/3SvXsea

Join us for a satellite symposium at the NSGC 43rd Annual Conference, where we'll explore different paths that help patients gain access and find answers, sooner. We look forward to seeing you there!​ Register now: genedx.co/3X9kv0V